Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Stomatitis × Diphenhydramine × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 4 Neoplasms 3 Neoplasm Metastasis 2 Carcinoma, Non-Small-Cell Lung 2 Stomatitis 1 Prostatic Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Oncology Patients Receiving Chemotherapy 1 Mucositis 1 Lymphoma, Large B-Cell, Diffuse 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia 1

Interventions

Fibroblast Growth Factor 7 7 Injections 3 Cisplatin 3 avasopasem manganese 2 Saline Solution 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 RRx-001 2 Mouthwashes 2 Low-Level Light Therapy 2 Drug Therapy 2 Benzydamine 2 meclocycline 1 hydrated silica gel-based toothpaste 1 dusquetide 1 cobiprostone 1 clazakizumab 1 brilacidin 1 aluminum hydroxide, magnesium hydroxide, drug combination 1 Xylitol 1 Whole-Body Irradiation 1 Water 1 Transplantation Conditioning 1 Standard of Care 1 Radiation 1 Prednisolone 1 Niacinamide 1 Methylprednisolone 1 Methotrexate 1 Lidocaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02606994 2019-02-06

TPvsM

Oral Defense, LLC

Phase 2 Terminated

Neoplasms, Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡